![Philippe Moingeon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philippe Moingeon
Geen lopende functies
Profiel
Philippe Moingeon served as Senior VP-Research & Pharmaceutical Development at Stallergenes SA from 2003 to 2012.
He holds an MBA from Harvard Medical School.
Eerdere bekende functies van Philippe Moingeon
Bedrijven | Functie | Einde |
---|---|---|
STALLERGENES | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Philippe Moingeon
Harvard Medical School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Stallergenes SA
![]() Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |